Willamette Valley Cancer Institute — Eugene, Oregon

Willamette Valley Cancer Institute is a clinical research site located in Eugene, Oregon, United States 97401-8122.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Willamette Valley Cancer Institute has participated in 13 clinical trials with 6 currently active.

Therapeutic areas: Endometrial Cancer, MPN (Myeloproliferative Neoplasms), Multiple Myeloma.

Sponsors: Incyte Corporation, Bristol-Myers Squibb, K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Willamette Valley Cancer Institute?

Willamette Valley Cancer Institute has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Willamette Valley Cancer Institute conducted?

Willamette Valley Cancer Institute has 13 clinical trials on record, with 6 currently active. Their work covers Endometrial Cancer, MPN (Myeloproliferative Neoplasms), Multiple Myeloma.

Is Willamette Valley Cancer Institute accredited by Crixeo Health?

Willamette Valley Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Willamette Valley Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.